Importantly, miR-3127 silencing resulted in epidermal growth factor (EGF)-induced downregulated HCC cell proliferation activity in low serum culture condition (Fig. 5D-F) suggesting that silencing miR-3127 inhibits HCC cell proliferation by blocking PI3K/AKT signaling. Here, AKT1 is linked to hepatocellular carcinoma.